
	Mr. Robert E. Gagnon, also known as Rob, has been Chief Financial Officer of Xenetic Biosciences, Inc. since January 2014. Mr. Gagnon has been Chief Financial Officer of Harvard Bioscience, Inc. since November 1, 2013. Mr. Gagnon served as Executive Vice President of Finance at Harvard Bioscience Inc. since October 23, 2013. Mr. Gagnon served as the Chief Financial Officer, Executive Vice President and Treasurer of Clean Harbors, Inc. since August 20, 2012 until February 04, 2013. From joining in 2005 to July 2012, Mr. Gagnon served in various positions at Biogen Idec, a public pharmaceuticals company. He served as Vice President of Business Planning of Biogen Idec Inc. since February 1, 2012 and served as its Controller since November 3, 2010. He served as the Chief Accounting Officer of Biogen Idec Inc. from November 3, 2010 to April 2, 2012. He served as Vice President of Biogen Idec from November 3, 2010 to February 1, 2012. Mr. Gagnon served as Vice President of Finance of Biogen Idec from July 2007 to November 2010 and its Director of Corporate Accounting from October 2005 to July 2007. He worked for PWC from 1995 to 1999, and served as its Senior Manager in the Audit and Assurance Services division. He served as Senior Director of Biogen Idec. He was a Senior Audit Manager and certified public accountant at Deloitte &amp; Touche, LLP and PricewaterhouseCoopers, LLP. He was Corporate Controller at eRoom Technology. A Certified Public Accountant, Mr. Gagnon holds an MBA degree with a finance concentration from the Massachusetts Institute of Technology and a BA degree in Accounting from Bentley College in 1995.
